<p style="line-height: 18.0pt;"><span style="font-family: 'Georgia',serif; color: #333333;">April 20, 2016</span></p>
<p style="line-height: 18.0pt; orphans: auto; text-align: start; widows: 1; -webkit-text-stroke-width: 0px; word-spacing: 0px;"><span style="font-family: 'Georgia',serif; color: #333333;">TBMH Suite 201</span></p>
<p style="line-height: 18.0pt; orphans: auto; text-align: start; widows: 1; -webkit-text-stroke-width: 0px; word-spacing: 0px;"><span style="font-family: 'Georgia',serif; color: #333333;">1 Riverside Circle</span></p>
<p style="line-height: 18.0pt; orphans: auto; text-align: start; widows: 1; -webkit-text-stroke-width: 0px; word-spacing: 0px;"><span style="font-family: 'Georgia',serif; color: #333333;">Roanoke, Virginia 24016</span></p>
Dr. Harald Sontheimer researches the biology of glial cells, the brain’s most abundant cell type. He is credited with making foundational discoveries on the functional properties of glial cells in the brain, including the localization and mechanisms of a range of receptors and ion channels that were previously thought to exist only on nerve cells.

Currently, Dr. Sontheimer studies the molecular structure and activity of glial cells in health, cancer, and other diseases. He and his research team work to understand the mechanisms underpinning the functions of glial cells, and how these functions may fault.

Dr. Sontheimer also currently serves on several councils and committees, including the Scientific Advisory Board “Cure Epilepsy”, the Scientific Advisory Board for the MIT Press, the Society for Neurochemistry Program Committee, the American Brain Tumor Association Scientific Advisory Council, and the College of CSR Reviewers. He previously served on the Scientific Advisory Board for The Max Plank Society. He also served as an editorial board member, in various capacities, for the <em>Journal of Neuroscience Letters</em>, <em>Glial</em>,<em>Jounal of Neuroscience Research</em>, <em>Glial-Neuronal Biology</em>, <em>NeuroReport</em>.